Diagnosis, Treatment and Prognosis of Cardiovascular Disease
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: closed (10 June 2022) | Viewed by 58154
Special Issue Editor
Interests: cardiovascular disease; cardiovascular rehabilitation; cardiology; coronary artery disease; heart failure; vascular medicine; atrial fibrillation; hypertension; cardiac imaging; cardiovascular neural control; autonomic nervous system; gender medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular disease represents a severe health burden, being the leading cause of morbidity and mortality worldwide. The COVID-19 pandemic has even worsened this scenario, as it has become evident that the presence of cardiovascular comorbidities negatively influences prognosis in the case of SARS-CoV-2 infection.
Within these perspectives, innovative strategies of prevention, early diagnosis, and optimization of medical and non-medical therapy should be implemented together with improvements in the organizational management of chronic cardiovascular disease.
Aging and an increasing number of comorbidities, both of which are accompanying heart disease with increasing frequency, further complicate the health challenges.
Acute and chronic coronary syndromes, heart failure, hypertensive cardiomyopathy, valve heart disease, and atrial fibrillation, to mention only the most common conditions, are often associated with diabetes, obesity, dyslipidemia and metabolic syndrome, peripheral artery disease, renal impairment, pulmonary disease, and cerebrovascular and neurodegenerative diseases.
Negative lifestyles, namely smoking, sedentary habits, and unhealthy eating and sleeping habits, also represent an important issue in terms of cardiovascular prevention and overall preventive medicine.
Thus, guidelines for diagnosis and treatment need to be personalized, taking into account many individual variables related to both the phenotypic expression of each disease and the individual’s genetics and epigenetics. Therefore, the role of precision medicine in cardiovascular disease should be better defined.
This Special Issue aims at investigating these complicated and challenging aspects, focusing on:
i)innovative diagnostic tools;
ii) identification of risk factors and indices of disease and prognosis;
iii) risk stratification and cardiovascular prevention;
iv) pharmacological and non-pharmacological therapy;
v) pathophysiology and phenotypic expression of cardiovascular diseases;
vi) mapping of individuals’ susceptibility to cardiovascular disease;
vii) cardiovascular rehabilitation;
viii) models of clinical management and healthcare, with particular attention to the transfer of guideline indications to the real world.
Dr. Laura Adelaide Dalla Vecchia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular risk factors
- heart disease
- coronary artery syndrome
- heart failure
- dyslipidemia
- cardiovascular guidelines
- personalized treatment
- optimal medical therapy
- cardiovascular rehabilitation
- cardiovascular genetics
- cardiovascular epigenetics
- precision medicine in cardiovascular disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.